Design Synthesis Characterization and Biological Evaluation of Benzothiazole Clubbed Pyrazole Derivatives as Target for Alzheimers Disease
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The present study involves designing and synthesizing of a novel series of 1,3-benzothiazole clubbed pyrazole derivatives through a novel method to develop multifunctional agents to target AD pathogenesis. The goal of developing compounds is to increase the inhibitory effects of cholinergic enzymes and study involves kinetic characterization of AchE and BchE inhibition, DPPH radical-scavenging potency, Peripheral anionic site (PAS) binding study, Amyloid-and#946; aggregation inhibition activity, PAMPA-BBB Assay, Drug likeness studies and Prediction of ADMET, blood-brain barrier (BBB) penetration properties. The introduction of different types of substituted chalcones and 2-hydrazino substituted 1,3-benzothiazoles with an aim to obtain newer and potent 1,3-benzothiazole clubbed pyrazole bioactive compounds which perpetuate to have significant enzymatic inhibition. Further, Pyrazoles have been reported as AD agents. These reports prompted us to undertake the synthesized a novel 1,3-benzothiazole clubbed pyrazole analogues with multifunctional agents for AD management properties.
newline